Skip to main content
Erschienen in: Breast Cancer Research and Treatment 2/2007

01.10.2007 | Epidemiology

Breast cancer risk factors and second primary malignancies among women with breast cancer

verfasst von: Amy Trentham-Dietz, Polly A. Newcomb, Hazel B. Nichols, John M. Hampton

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2007

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To examine the association between breast cancer risk factors and second primary cancers (independent diagnoses occurring at least 12 months after the initial breast cancer diagnosis) among breast cancer survivors.

Methods

In this population-based study, cancer outcomes among breast cancer survivors first diagnosed during 1987–2000 were investigated. Invasive breast cancer cases were identified from the statewide tumor registry and interviewed regarding their pre-diagnosis risk factors, including reproductive and lifestyle characteristics, approximately 1 year after diagnosis. Data on second primary cancers (not recurrences) and deaths were obtained by linkage with tumor registry reports and death certificates through December 31, 2002. Hazard ratios (HR) were estimated using proportional hazards regression stratified by age and adjusted for stage and other factors.

Results

Among the 10,953 breast cancer cases, 10.8% experienced a second cancer diagnosis within an average of 7 years (including 488 breast, 132 colorectal, 113 endometrial, and 36 ovarian cancers). Risk of a second primary breast cancer increased according to low parity (P = 0.002), older age at menopause (P = 0.08), greater body mass index (P = 0.003) and adult weight gain (P = 0.02), and a family history of breast cancer-particularly among women with 2 or more first-degree affected relatives (HR = 1.8, 95% CI: 1.1–2.9). Reduced risk of colorectal cancer after breast cancer was observed in relation to older ages at menarche (P = 0.05), younger age at menopause (P = 0.04), postmenopausal hormone use (HR = 0.4, 95% CI: 0.3–0.7), normal body mass index (P = 0.07), and infrequent alcohol consumption (P = 0.01). Second endometrial cancer risk was associated with increasing body mass index (P < 0.01) and adult weight gain (P = 0.03). Risk of second ovarian cancer appeared related to recent alcohol intake and family history of breast cancer. Women who reported consuming any alcohol appeared to have a 55% reduction in ovarian cancer risk (95% CI: 0.2–1.0) compared to non-drinkers, while having 2 or more first-degree relatives with breast cancer was associated with an increased risk of ovarian cancer (HR = 4.3, 95% CI: 1.3–14.6).

Conclusion

This study suggests that family history of breast cancer as well as potentially modifiable characteristics including body weight, alcohol intake, and postmenopausal hormone use may be associated with risk of a second cancer diagnosis among breast cancer cases.
Literatur
1.
Zurück zum Zitat Travis LB, Rabkin CS, Brown LM et al (2006) Cancer survivorship – genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst 98(1):15–25PubMedCrossRef Travis LB, Rabkin CS, Brown LM et al (2006) Cancer survivorship – genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst 98(1):15–25PubMedCrossRef
2.
Zurück zum Zitat Horn-Ross PL (1993) Multiple primary cancers involving the breast. Epidemiol Rev 15(1):169–176PubMed Horn-Ross PL (1993) Multiple primary cancers involving the breast. Epidemiol Rev 15(1):169–176PubMed
3.
Zurück zum Zitat Chen Y, Thompson W, Semenciw R, Mao Y (1999) Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 8(10):855–861PubMed Chen Y, Thompson W, Semenciw R, Mao Y (1999) Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev 8(10):855–861PubMed
4.
Zurück zum Zitat Soerjomataram I, Louwman WJ, Lemmens VE et al (2005) Risks of second primary breast and urogenital cancer following female breast cancer in the south of The Netherlands, 1972–2001. Eur J Cancer 41(15):2331–2337PubMedCrossRef Soerjomataram I, Louwman WJ, Lemmens VE et al (2005) Risks of second primary breast and urogenital cancer following female breast cancer in the south of The Netherlands, 1972–2001. Eur J Cancer 41(15):2331–2337PubMedCrossRef
5.
Zurück zum Zitat Mellemkjaer L, Friis S, Olsen JH et al (2006) Risk of second cancer among women with breast cancer. Int J Cancer 118(9):2285–2292PubMedCrossRef Mellemkjaer L, Friis S, Olsen JH et al (2006) Risk of second cancer among women with breast cancer. Int J Cancer 118(9):2285–2292PubMedCrossRef
6.
Zurück zum Zitat Harvey EB, Brinton LA (1985) Second cancer following cancer of the breast in Connecticut, 1935–82. Natl Cancer Inst Monogr 68:99–112PubMed Harvey EB, Brinton LA (1985) Second cancer following cancer of the breast in Connecticut, 1935–82. Natl Cancer Inst Monogr 68:99–112PubMed
7.
Zurück zum Zitat Volk N, Pompe-Kirn V (1997) Second primary cancers in breast cancer patients in Slovenia. Cancer Causes Control 8(5):764–770PubMedCrossRef Volk N, Pompe-Kirn V (1997) Second primary cancers in breast cancer patients in Slovenia. Cancer Causes Control 8(5):764–770PubMedCrossRef
8.
Zurück zum Zitat Soerjomataram I, Louwman WJ, de Vries E et al (2005) Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972–2001. Breast Cancer Res Treat 93(1):91–95PubMedCrossRef Soerjomataram I, Louwman WJ, de Vries E et al (2005) Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972–2001. Breast Cancer Res Treat 93(1):91–95PubMedCrossRef
9.
Zurück zum Zitat Escobar PF, Patrick R, Rybicki L et al (2006) Primary gynecological neoplasms and clinical outcomes in patients diagnosed with breast carcinoma. Int J Gynecol Cancer 16(Suppl 1):118–122PubMedCrossRef Escobar PF, Patrick R, Rybicki L et al (2006) Primary gynecological neoplasms and clinical outcomes in patients diagnosed with breast carcinoma. Int J Gynecol Cancer 16(Suppl 1):118–122PubMedCrossRef
10.
Zurück zum Zitat Raymond JS, Hogue CJ (2006) Multiple primary tumours in women following breast cancer, 1973–2000. Br J Cancer 94(11):1745–1750PubMed Raymond JS, Hogue CJ (2006) Multiple primary tumours in women following breast cancer, 1973–2000. Br J Cancer 94(11):1745–1750PubMed
11.
Zurück zum Zitat Strom BL, Schinnar R, Weber AL et al (2006) Case–control study of postmenopausal hormone replacement therapy and endometrial cancer. Am J Epidemiol 164(8):775–786PubMedCrossRef Strom BL, Schinnar R, Weber AL et al (2006) Case–control study of postmenopausal hormone replacement therapy and endometrial cancer. Am J Epidemiol 164(8):775–786PubMedCrossRef
12.
Zurück zum Zitat Newcomb PA, Solomon C, White E (1999) Tamoxifen and risk of large bowel cancer in women with breast cancer. Breast Cancer Res Treat 53(3):271–277PubMedCrossRef Newcomb PA, Solomon C, White E (1999) Tamoxifen and risk of large bowel cancer in women with breast cancer. Breast Cancer Res Treat 53(3):271–277PubMedCrossRef
13.
Zurück zum Zitat Slomovitz BM, Sun CC, Ramirez PT et al (2004) Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer? Obstet Gynecol 104(2):255–260PubMed Slomovitz BM, Sun CC, Ramirez PT et al (2004) Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer? Obstet Gynecol 104(2):255–260PubMed
14.
Zurück zum Zitat Matesich SM, Shapiro CL (2003) Second cancers after breast cancer treatment. Semin Oncol 30(6):740–748PubMedCrossRef Matesich SM, Shapiro CL (2003) Second cancers after breast cancer treatment. Semin Oncol 30(6):740–748PubMedCrossRef
15.
Zurück zum Zitat Bernstein JL, Thompson WD, Risch N, Holford TR (1992) The genetic epidemiology of second primary breast cancer. Am J Epidemiol 136(8):937–948PubMed Bernstein JL, Thompson WD, Risch N, Holford TR (1992) The genetic epidemiology of second primary breast cancer. Am J Epidemiol 136(8):937–948PubMed
16.
Zurück zum Zitat Trentham-Dietz A, Newcomb PA, Storer BE et al (1997) Body size and risk of breast cancer. Am J Epidemiol 145(11):1011–1019PubMed Trentham-Dietz A, Newcomb PA, Storer BE et al (1997) Body size and risk of breast cancer. Am J Epidemiol 145(11):1011–1019PubMed
17.
Zurück zum Zitat Trentham-Dietz A, Newcomb PA, Storer BE, Remington PL (2000) Risk factors for carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev 9(7):697–703PubMed Trentham-Dietz A, Newcomb PA, Storer BE, Remington PL (2000) Risk factors for carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev 9(7):697–703PubMed
18.
Zurück zum Zitat Wisconsin Cancer Incidence and Mortality (1999) Madison: Bureau of Health Information, Division of Health Care Financing, Wisconsin Department of Health and Family Services, 2002 Wisconsin Cancer Incidence and Mortality (1999) Madison: Bureau of Health Information, Division of Health Care Financing, Wisconsin Department of Health and Family Services, 2002
19.
Zurück zum Zitat International Classification of Disease for Oncology, 3rd edn. World Health Organization, Geneva, 2000 International Classification of Disease for Oncology, 3rd edn. World Health Organization, Geneva, 2000
20.
Zurück zum Zitat Gooley TA, Leisenring W, Crowley J, Storer BE (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18(6):695–706PubMedCrossRef Gooley TA, Leisenring W, Crowley J, Storer BE (1999) Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18(6):695–706PubMedCrossRef
21.
Zurück zum Zitat Trentham-Dietz A, Newcomb PA, Egan KM et al (2000) Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control 11(6):533–542PubMedCrossRef Trentham-Dietz A, Newcomb PA, Egan KM et al (2000) Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control 11(6):533–542PubMedCrossRef
22.
Zurück zum Zitat Armstrong BK, White E, Saracci R (1995) Principles of exposure measurement in epidemiology. In: Monographs in epidemiology and biostatistics. Oxford, New York, pp 78–114 Armstrong BK, White E, Saracci R (1995) Principles of exposure measurement in epidemiology. In: Monographs in epidemiology and biostatistics. Oxford, New York, pp 78–114
23.
Zurück zum Zitat Newcomb PA, Titus-Ernstoff L, Egan KM et al (2002) Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev 11(7):593–600PubMed Newcomb PA, Titus-Ernstoff L, Egan KM et al (2002) Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev 11(7):593–600PubMed
24.
Zurück zum Zitat Cole P, MacMahon B, Brown JB (1976) Oestrogen profiles of parous and nulliparous women. Lancet 2(7986):596–599PubMedCrossRef Cole P, MacMahon B, Brown JB (1976) Oestrogen profiles of parous and nulliparous women. Lancet 2(7986):596–599PubMedCrossRef
25.
Zurück zum Zitat McMichael AJ, Potter JD (1980) Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst 65(6):1201–1207PubMed McMichael AJ, Potter JD (1980) Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst 65(6):1201–1207PubMed
26.
Zurück zum Zitat Fowble B, Hanlon A, Freedman G, Nicolaou N, Anderson P (2001) Second cancers after conservative surgery and radiation for stages I–II breast cancer: identifying a subset of women at increased risk. Int J Radiat Oncol Biol Phys 51(3):679–690PubMedCrossRef Fowble B, Hanlon A, Freedman G, Nicolaou N, Anderson P (2001) Second cancers after conservative surgery and radiation for stages I–II breast cancer: identifying a subset of women at increased risk. Int J Radiat Oncol Biol Phys 51(3):679–690PubMedCrossRef
27.
Zurück zum Zitat Dignam JJ, Wieand K, Johnson KA et al (2003) Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 95(19):1467–1476PubMed Dignam JJ, Wieand K, Johnson KA et al (2003) Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst 95(19):1467–1476PubMed
28.
Zurück zum Zitat Hislop TG, Elwood JM, Coldman AJ et al (1984) Second primary cancers of the breast: incidence and risk factors. Br J Cancer 49(1):79–85PubMed Hislop TG, Elwood JM, Coldman AJ et al (1984) Second primary cancers of the breast: incidence and risk factors. Br J Cancer 49(1):79–85PubMed
29.
Zurück zum Zitat Horn PL, Thompson WD (1988) Risk of contralateral breast cancer: associations with factors related to initial breast cancer. Am J Epidemiol 128(2):309–323PubMed Horn PL, Thompson WD (1988) Risk of contralateral breast cancer: associations with factors related to initial breast cancer. Am J Epidemiol 128(2):309–323PubMed
30.
Zurück zum Zitat Cook LS, White E, Schwartz SM et al (1996) A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States). Cancer Causes Control 7(3):382–390PubMedCrossRef Cook LS, White E, Schwartz SM et al (1996) A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States). Cancer Causes Control 7(3):382–390PubMedCrossRef
31.
Zurück zum Zitat Vaittinen P, Hemminki K (2000) Risk factors and age-incidence relationships for contralateral breast cancer. Int J Cancer 88(6):998–1002PubMedCrossRef Vaittinen P, Hemminki K (2000) Risk factors and age-incidence relationships for contralateral breast cancer. Int J Cancer 88(6):998–1002PubMedCrossRef
32.
Zurück zum Zitat Li CI, Malone KE, Porter PL, Daling JR (2003) Epidemiologic and molecular risk factors for contralateral breast cancer among young women. Br J Cancer 89(3):513–158PubMedCrossRef Li CI, Malone KE, Porter PL, Daling JR (2003) Epidemiologic and molecular risk factors for contralateral breast cancer among young women. Br J Cancer 89(3):513–158PubMedCrossRef
33.
Zurück zum Zitat Storm HH, Andersson M, Boice JD Jr et al (1992) Adjuvant radiotherapy and risk of contralateral breast cancer. J Natl Cancer Inst 84(16):1245–1250PubMedCrossRef Storm HH, Andersson M, Boice JD Jr et al (1992) Adjuvant radiotherapy and risk of contralateral breast cancer. J Natl Cancer Inst 84(16):1245–1250PubMedCrossRef
34.
Zurück zum Zitat Bernstein JL, Thompson WD, Risch N, Holford TR (1992) Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. Am J Epidemiol 136(8):925–936PubMed Bernstein JL, Thompson WD, Risch N, Holford TR (1992) Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. Am J Epidemiol 136(8):925–936PubMed
35.
Zurück zum Zitat Weight Control and Physical Activity (2002) IARC Press, Lyon, France Weight Control and Physical Activity (2002) IARC Press, Lyon, France
36.
Zurück zum Zitat Kroenke CH, Chen WY, Rosner B, Holmes MD (2005) Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 23(7):1370–1378PubMedCrossRef Kroenke CH, Chen WY, Rosner B, Holmes MD (2005) Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 23(7):1370–1378PubMedCrossRef
37.
Zurück zum Zitat Bernstein JL, Lapinski R, Lynch C, Holford T, Thompson WD (2002) Factors influencing mortality among young women with second primary breast carcinoma. Cancer 95(10):2051–2058PubMedCrossRef Bernstein JL, Lapinski R, Lynch C, Holford T, Thompson WD (2002) Factors influencing mortality among young women with second primary breast carcinoma. Cancer 95(10):2051–2058PubMedCrossRef
39.
Zurück zum Zitat Gunnell DJ, Smith GD, Frankel SJ, Kemp M, Peters TJ (1998) Socio-economic and dietary influences on leg length and trunk length in childhood: a reanalysis of the Carnegie (Boyd Orr) survey of diet and health in prewar Britain (1937–39). Paediatr Perinat Epidemiol 12(Suppl 1):96–113PubMedCrossRef Gunnell DJ, Smith GD, Frankel SJ, Kemp M, Peters TJ (1998) Socio-economic and dietary influences on leg length and trunk length in childhood: a reanalysis of the Carnegie (Boyd Orr) survey of diet and health in prewar Britain (1937–39). Paediatr Perinat Epidemiol 12(Suppl 1):96–113PubMedCrossRef
40.
Zurück zum Zitat Gram IT, Braaten T, Terry PD et al (2005) Breast cancer risk among women who start smoking as teenagers. Cancer Epidemiol Biomarkers Prev 14(1):61–66PubMed Gram IT, Braaten T, Terry PD et al (2005) Breast cancer risk among women who start smoking as teenagers. Cancer Epidemiol Biomarkers Prev 14(1):61–66PubMed
41.
Zurück zum Zitat Kurtz JM, Spitalier JM, Amalric R et al (1988) Mammary recurrences in women younger than forty. Int J Radiat Oncol Biol Phys 15(2):271–276PubMedCrossRef Kurtz JM, Spitalier JM, Amalric R et al (1988) Mammary recurrences in women younger than forty. Int J Radiat Oncol Biol Phys 15(2):271–276PubMedCrossRef
42.
Zurück zum Zitat Boice JD Jr, Harvey EB, Blettner M, Stovall M, Flannery JT (1992) Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 326(12):781–785PubMedCrossRef Boice JD Jr, Harvey EB, Blettner M, Stovall M, Flannery JT (1992) Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 326(12):781–785PubMedCrossRef
43.
Zurück zum Zitat Kmet LM, Cook LS, Weiss NS, Schwartz SM, White E (2003) Risk factors for colorectal cancer following breast cancer. Breast Cancer Res Treat 79(2):143–147PubMedCrossRef Kmet LM, Cook LS, Weiss NS, Schwartz SM, White E (2003) Risk factors for colorectal cancer following breast cancer. Breast Cancer Res Treat 79(2):143–147PubMedCrossRef
44.
Zurück zum Zitat Martinez ME, Grodstein F, Giovannucci E et al (1997) A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 6(1):1–5PubMed Martinez ME, Grodstein F, Giovannucci E et al (1997) A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 6(1):1–5PubMed
45.
Zurück zum Zitat Fernandez E, La Vecchia C, Franceschi S et al (1998) Oral contraceptive use and risk of colorectal cancer. Epidemiology 9(3):295–300PubMedCrossRef Fernandez E, La Vecchia C, Franceschi S et al (1998) Oral contraceptive use and risk of colorectal cancer. Epidemiology 9(3):295–300PubMedCrossRef
46.
Zurück zum Zitat Nichols HB, Trentham-Dietz A, Hampton JM, Newcomb PA (2005) Oral contraceptive use, reproductive factors, and colorectal cancer risk: findings from Wisconsin. Cancer Epidemiol Biomarkers Prev 14(5):1212–1218PubMedCrossRef Nichols HB, Trentham-Dietz A, Hampton JM, Newcomb PA (2005) Oral contraceptive use, reproductive factors, and colorectal cancer risk: findings from Wisconsin. Cancer Epidemiol Biomarkers Prev 14(5):1212–1218PubMedCrossRef
47.
Zurück zum Zitat Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results f rom the Women’s Health Initiative randomized controlled trial. JAMA 288(3):321–333PubMedCrossRef Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results f rom the Women’s Health Initiative randomized controlled trial. JAMA 288(3):321–333PubMedCrossRef
48.
Zurück zum Zitat Metcalfe KA, Lynch HT, Ghadirian P et al (2005) The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers. Gynecol Oncol 96(1):222–226PubMedCrossRef Metcalfe KA, Lynch HT, Ghadirian P et al (2005) The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers. Gynecol Oncol 96(1):222–226PubMedCrossRef
Metadaten
Titel
Breast cancer risk factors and second primary malignancies among women with breast cancer
verfasst von
Amy Trentham-Dietz
Polly A. Newcomb
Hazel B. Nichols
John M. Hampton
Publikationsdatum
01.10.2007
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 2/2007
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9446-y

Weitere Artikel der Ausgabe 2/2007

Breast Cancer Research and Treatment 2/2007 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.